Real-time enrollment status for this primary open angle glaucoma (poag) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:33 PM UTC
| NCT Number | NCT07675824 |
| Recruiting Status | Recruiting |
| Condition | Primary Open Angle Glaucoma (POAG) |
| Phase | PHASE1 |
| Target Enrollment | 271 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07675824 is currently recruiting participants. This phase1 study for primary open angle glaucoma (poag) is actively seeking new participants at 1 location across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07675824 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07675824 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.